Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$884,274
+$315,448 QoQ
Shares Held
106,411
+98.3% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. ARVN ranks #145 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $884,274 | 106,411 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $568,826 | 53,663 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,203,978 | 101,516 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $712,833 | 83,666 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $595,267 | 80,879 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $357,969 | 50,993 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $797,663 | 41,610 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,487,625 | 60,399 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,184,383 | 82,058 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,163,573 | 76,637 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,435,147 | 59,163 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,197,920 | 60,994 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,929,306 | 77,732 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,854,617 | 67,885 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,241,951 | 65,535 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,713,354 | 60,988 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,456,160 | 58,355 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,761,954 | 85,616 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,721,979 | 94,010 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,646,059 | 80,872 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,558,785 | 59,205 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,880,399 | 58,705 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $7,543,141 | 88,816 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,193,533 | 92,907 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,052,843 | 91,021 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,814,349 | 69,835 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||